Efficacy of carboplatin plus S-1 for the treatment of non-small cell lung cancer: A protocol for a systematic review of randomized controlled trial

BACKGROUND: Non-small cell lung cancer (NSCLC) is the most common lung cancer. Numerous clinical studies have reported that the combination of carboplatin and S-1 (CS) can be used to treat NSCLC effectively. However, no systematic review has been conducted to assess its efficacy and safety for NSCLC...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Lei, Wei, Zhou-Xia, Lv, Yu-Feng, Jiang, Ai-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455708/
https://www.ncbi.nlm.nih.gov/pubmed/30946371
http://dx.doi.org/10.1097/MD.0000000000015099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455708/
https://www.ncbi.nlm.nih.gov/pubmed/30946371
http://dx.doi.org/10.1097/MD.0000000000015099

Ejemplares similares